Melanoma Patients Suffer Side Effects of Checkpoint Inhibitors, Yet Maintain QoL
November 19th 2015Advanced melanoma patients successfully treated with a combination of nivolumab and ipilimumab may endure severe side effects, but they do not suffer any clinically meaningful changes in health-related quality of life.